| Prevalence of psychoactive substance use Prevalence of medication use Prevalence of drug use Drug prevention Treatment supply Treatment demand Health consequences Harm reduction Drug-related crimes Drug market Drug use and prison Monitoring of publications Attitudes to legal framework changes |
Prevalence of HIV, hepatitis B/C, syphilis infection among people who inject drugs (PWID) in 2024
| HIV (anti-HIV) | Hepatitis В (HbsAg) | Hepatitis С (anti-HCV) | Syphilis | |
| Total number of PWID who were tested | 150 | 150 | 150 | 149 |
| Males | 99 | 99 | 99 | 99 |
| Females | 49 | 49 | 49 | 48 |
| No data | 2 | 2 | 2 | 2 |
| Number of PWID with a positive test result | 18 | 3 | 107 | 10 |
| Males | 17 | 2 | 76 | 5 |
| Females | 1 | 1 | 30 | 5 |
| No data | 1 | |||
| Proportion positive (%) | 12.0% | 2.0% | 71.3% | 6.7% |
| Males | 17.2% | 2.0% | 76.8% | 5.1% |
| Females | 2.0% | 2.0% | 61.2% | 10.4% |
Prevalence of HIV, hepatitis B/C and syphilis infection among people who inject drugs (PWID) in 2024 (by age groups)
| HIV (anti-HIV) | Hepatitis В (HbsAg) | Hepatitis С (anti-HCV) | Syphilis | |
| Age <25 | ||||
| Number of PWID who were tested | 3 | 3 | 3 | 3 |
| Number of PWID with a positive test result | 0 | 0 | 0 | 0 |
| Proportion positive (%) | 0.0% | 0.0% | 0.0% | 0.0% |
| Age 25-34 | ||||
| Number of PWID who were tested | 18 | 18 | 18 | 18 |
| Number of PWID with a positive test result | 2 | 0 | 8 | 0 |
| Proportion positive (%) | 11.1% | 0.0% | 44.4% | 0.0% |
| Age > 34 | ||||
| Number of PWID who were tested | 129 | 129 | 129 | 128 |
| Number of PWID with a positive test result | 16 | 3 | 99 | 10 |
| Proportion positive (%) | 12.4% | 2.3% | 76.7% | 7.8% |
Prevalence of HIV, hepatitis B/C and syphilis infection among people who inject drugs (PWID) in 2024 (by years since first injection)
| HIV (anti-HIV) | Hepatitis В (HbsAg) | Hepatitis С (anti-HCV) | Syphilis | |
| <2 years since first injection | ||||
| Number of PWID who were tested | 3 | 3 | 3 | 3 |
| Number of PWID with a positive test result | 0 | 0 | 0 | 0 |
| Proportion positive (%) | 0.0% | 0.0% | 0.0% | 0.0 |
| 2 to 4 years since first injection | ||||
| Number of PWID who were tested | 4 | 4 | 4 | 4 |
| Number of PWID with a positive test result | 0 | 0 | 0 | 0 |
| Proportion positive (%) | 0.0% | 0.0% | 0.0% | 0.0% |
| 5 to 9 years since first injection | ||||
| Number of PWID who were tested | 7 | 7 | 7 | 7 |
| Number of PWID with a positive test result | 0 | 0 | 1 | 0 |
| Proportion positive (%) | 0.0% | 0.0% | 24.3% | 0.0% |
| 10 or more years since first injection | ||||
| Number of PWID who were tested | 134 | 134 | 134 | 133 |
| Number of PWID with a positive test result | 18 | 3 | 106 | 10 |
| Proportion positive (%) | 13.4% | 2.2% | 79.1% | 7.5% |
| No data | 2 | 2 | 2 | 2 |
Prevalence of HIV, hepatitis B/C and syphilis infection among people who inject drugs (PWID) in 2024 (by primary drug)
| HIV (anti-HIV) | Hepatitis В (HbsAg) | Hepatitis С (anti-HCV) | Syphilis | |
| PWID with primary drug opioids | ||||
| Number of PWID who were tested | 131 | 131 | 131 | 130 |
| Number of PWID with a positive test result | 18 | 3 | 107 | 10 |
| Proportion positive (%) | 13.7% | 2.3% | 81.7% | 7.7% |
| PWID with primary drug cocaine | ||||
| Number of PWID who were tested | 9 | 9 | 9 | 9 |
| Number of PWID with a positive test result | 0 | 0 | 0 | 0 |
| Proportion positive (%) | 0.0% | 0.0% | 0.0% | 0.0% |
| PWID with primary drug stimulants other than cocaine | ||||
| Number of PWID who were tested | 10 | 10 | 10 | 10 |
| Number of PWID with a positive test result | 0 | 0 | 0 | 0 |
| Proportion positive (%) | 0.0% | 0.0% | 0.0% | 0.0% |
Prevalence of HIV, hepatitis B/C and syphilis infection among people who inject drugs (PWID) in 2024 (by contact with drug treatment in the last 12 months)
| HIV (anti-HIV) | Hepatitis В (HbsAg) | Hepatitis С (anti-HCV) | Syphilis | |
| PWID who have been in contact with drug treatment services in the last 12 months | ||||
| Number of PWID who were tested | 131 | 131 | 131 | 131 |
| Number of PWID with a positive test result | 18 | 3 | 105 | 10 |
| Proportion positive (%) | 13.7% | 2.3% | 80.2% | 7.6% |
| PWID who have not been in contact with drug treatment services in the last 12 months | ||||
| Number of PWID who were tested | 15 | 15 | 15 | 14 |
| Number of PWID with a positive test result | 0 | 0 | 2 | 0 |
| Proportion positive (%) | 0.0% | 0.0% | 13.3% | 0.0% |
| PWID with missing information on drug treatment contact | ||||
| Number of PWID who were tested | 4 | 4 | 4 | 4 |
| Number of PWID with a positive test result | 0 | 0 | 0 | 0 |
Prevalence of HIV, hepatitis B/C and syphilis infection among people who inject drugs (PWID) in 2024 (by imprisonment)
| HIV (anti-HIV) | Hepatitis В (HbsAg) | Hepatitis С (anti-HCV) | Syphilis | |
| PWID ever in prison | ||||
| Number of PWID who were tested | 1 | 1 | 1 | 1 |
| Number of PWID with a positive test result | 0 | 0 | 0 | 0 |
| Proportion positive (%) | 0.0% | 0.0% | 0.0% | 0.0% |
| PWID never in prison | ||||
| Number of PWID who were tested | 28 | 28 | 28 | 27 |
| Number of PWID with a positive test result | 3 | 1 | 9 | 0 |
| Proportion positive (%) | 10.7% | 3.6% | 32.1% | 0.0% |
| No data | ||||
| Number of PWID who were tested | 121 | 121 | 121 | 121 |
| Number of PWID with a positive test result | 15 | 2 | 98 | 10 |
Source: State Psychiatric Hospital for Treatment of Drug Addiction and Alcoholism (SPHTDAA), Sofia, NFP, NCPHA